Exploration of Multiple Non‐Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients with <scp>MASH</scp>
NITs may be used for assessing a treatment response in patients with MASH. Further studies should confirm the treatment effect of NITs and evaluate the association of NIT changes to outcomes.
Authors
- Jan Fleckner
- Vlad Ratziu (ORCID: https://orcid.org/0000-0002-3051-0111)
- Clare A. Balendran (ORCID: https://orcid.org/0000-0003-2835-1673)
- Quentin M. Anstee (ORCID: https://orcid.org/0000-0002-9518-0088)
- Arun Jayant Sanyal (ORCID: https://orcid.org/0000-0001-8682-5748)
- Louise Maymann Nitze
- Mette Skalshøi Kjær (ORCID: https://orcid.org/0000-0001-6322-4077)
- Vincent Wai‐Sun Wong (ORCID: https://orcid.org/0000-0003-2215-9410)
- Niels Krarup
Institutions
- Inserm (FR)
- Chinese University of Hong Kong (HK)
- Virginia Commonwealth University (US)
- Novo Nordisk (Denmark) (DK)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- NIHR Newcastle Biomedical Research Centre (GB)
- Fondation pour l’innovation en Cadiométabolisme et Nutrition (FR)
- Newcastle University (GB)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1111/apt.70376
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Novo Nordisk